The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Well done Septic Peg! But actually the impact doesn't matter if you have a little foresight and patience.
Spot on. Nice to see someone seeing it for what it is. I still think sng has potential tho but it won’t be quick like many believe
Sharp eye clearly mortgaged his future on SNG. Relax, don’t hate me because I called today’s rns would have no impact and in sorry you’ve done your savings or whatever and it’s currently in the red.
Unfortunately the market sees this rns as a non event. They annoucned a partner to help them, no peer review yet and I assume witrhout a peer review it will be difficult to get a fast rtack approval
City Trader,
SNG are wearing big boy pants now. With the SP at these levels only amazing news will move it forward dramatically. What everyone needs to understand is that amazing news does not come in one RNS. It takes several and I think this will be the first of many!
GLA
Think the fact their first post looks like it was written by a 4 year old seriously behind in their English class would suggest it wasn’t one to be taking any notice of. Utter waste of time some of the dross that creeps onto these bbs
The market really does not understand this RNS.
This is a great RNS and happy to see this treatment with huge potential to prevent a lot of deaths and economic carnarge now available to select patients.
However, I see the most benefit potentially as a treatment early in the illness and this will need verification with results from the 'at home' trial. I can't believe that Boris plans (allegedly) to spend another £100 billion of our hard earned on 'Moonshot'. yet the at home trial is struggling without sufficient government support. I will be writing to my MP today.
16%gains, you really are a fallacious little twerp aren't you. Just re-read your first message here on SYG, here it is;
I have been studying this company for 2 months now and I’m telling you it’s a boomer. What you are seeing right now is nothing. Richard, Carl and Sarah begins the scenes have all got a partnership lined up but I can’t say with who but watch this space over the next week. Internally they have set a target price to staff of 3000 by end of September as they’re ya getting massive sails in Africa where vaccination isn’t plausible. I’ve said to much.
What a load of tosh, and now you have the gall to claim Cassandra like foresight. Go crawl under your rock you slug.
16% you boring mug y do you bother posting
Price will badly move so let’s see what a big deal these rns truly are. Shock I was right.
Oh **** off you sad little twat
Where’s the boom from this good news?! What am I not getting HAHAHAHA
https://www.clinigengroup.com/about-cliniport/
Details what clinigens managed access program provides, all positive for me!
Barely ^^
Well said, benbenbenben. Looks like a real nice climb from here. Exciting times ahead.
Price will badly move so let’s see what a big deal these rns truly are.
IDK i'd say its fairly significant - a global distribution partner; ramping up of manufacturing; pre-regulatory-approval market access for the drug; preparation of a wider clinical evidence base for regulatory approval; strong cash position; etc, etc... looks pretty good to me!
'Clinigen now has over 1,100 employees across five continents in 14 countries, with supply and distribution hubs and operational centres of excellence in key long-term growth regions. The Group works with 22 of the top 25 pharmaceutical companies; interacting with over 15,000 registered users across over 100 countries, shipping approximately 6.4 million units in the year.'
A Great way to get the ball rolling before regulatory approvals received...
No mention of other negotiations with distributors or Pharmas though...
Nothing big there. The cult prob think price will hit 500 or something and will find any excuse to blame everything else when it barely moves.